Autologous Tumor Vaccine Modified with Recombinant New Castle Disease Virus Expressing IL-7 Promotes Antitumor Immune Response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Autologous Tumor Vaccine Modified with Recombinant New Castle Disease Virus Expressing IL-7 Promotes Antitumor Immune Response

Published:2014-06-18 Issue:2 Volume:193 Page:735-745
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Zhao Lixiang,Mei Yu,Sun Qing,Guo Linghua,Wu Yan,Yu Xiao,Hu Bo,Liu Xiufan,Liu Haiyan

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. Viruses in the treatment of cancer.;Csatary;Lancet,1971

2. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.;Lorence;Cancer Res.,1994

3. Complete Regression of Human Neuroblastoma Xenografts in Athymic Mice After Local Newcastle Disease Virus Therapy

4. Newcastle Disease Virus as an Antineoplastic Agent: Induction of Tumor Necrosis Factor- and Augmentation of Its Cytotoxicity2

5. Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of gut microbes-related molecular subtypes and their biomarkers in colorectal cancer;Aging;2024-01-29

2. Oncolytic viral therapy as promising immunotherapy against glioma;MedComm – Future Medicine;2023-10-16

3. IL-7: Comprehensive review;Cytokine;2022-12

4. Intravenous injection of a novel viral immunotherapy encoding human interleukin-7 in nonhuman primates is safe and increases absolute lymphocyte count;Human Vaccines & Immunotherapeutics;2022-10-31

5. IL-7: A promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines?;Frontiers in Immunology;2022-10-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3